EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Topoisomerase I inhibition yields a CD74high/MHChigh human microglial subtype with enhanced Aβ uptake

Verena Haage, John F Tuddenham, Natacha Comandante-Lou, Alex R Bautista, Anna S Monzel, Frankie G Garcia, Rebecca Chiu, Masashi Fujita, Prabesh Bhattarai, Charles C White, Ronak Patel, Alice Buonfiglioli und 20 weitere

Cell Reports · 2026-10 · 45 (10) · 118031

DOI: 10.1016/j.celrep.2026.118031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-10. Verfasst von Verena Haage und 31 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational & Computational Neuroimmunology, Neuroimmunology Division, Department of Neurology and the Taub Institute for Research on Al…. Hauptthemen laut MEDLINE: Microglia, Antigens, Differentiation, B-Lymphocyte, Topoisomerase I Inhibitors, Histocompatibility Antigens Class II. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, The Chan Zuckerberg Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While efforts to identify microglial subtypes have recently accelerated, the relation of transcriptomically defined states to cellular function has been largely limited to in silico annotations. Here, we characterize two topoisomerase I inhibitors that polarize human microglia toward a distinct state characterized by increased antigen presentation gene expression. Using HMC3 cells, iPSC-derived microglia, and cerebral organoids, we show that Camptothecin induces a CD74high/MHChigh microglia-like cell subtype specialized in amyloid beta phagocytosis and reduced IL-6, IL-8, and MCP-1 secretion in response to TNF-α stimulation. Moreover, Camptothecin suppresses amyloid toxicity and restores microglia to their homeostatic morphology in a zebrafish amyloid proteinopathy model. We also identify Topotecan, a Food and Drug Administration (FDA)-approved Camptothecin analog, as a driver of the CD74high/MHChigh signature. This report provides a reproducible approach to recapitulate a human microglial state in vitro, enabling its functional characterization and providing a foundation for rational modulation of human microglia in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaAntigens, Differentiation, B-LymphocyteTopoisomerase I InhibitorsHistocompatibility Antigens Class IIAmyloid beta-PeptidesHumansZebrafishAnimalsCamptothecinPhagocytosisTopotecanInterleukin-8

Stichwörter der Autor:innen

CP: neurosciencehuman microgliain silico drug screeningin vitro models for human microglial subtypesmicroglia subtypesmitochondrial phenotypingsingle cell

Substanzen

invariant chainAntigens, Differentiation, B-LymphocyteTopoisomerase I InhibitorsHistocompatibility Antigens Class IIAmyloid beta-PeptidesCamptothecinTopotecanInterleukin-8

Autor:innen und Institutionen

  • Center for Translational & Computational Neuroimmunology, Neuroimmunology Division, Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medi…
  • Department of Psychiatry, Division of Behavioral Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA; Department of Neurology, H. Houston Merritt Center, Columbia T…
  • Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Department of Pathology and Cell Biology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Department of Psychiatry, Icahn School of Medicine, 1460 Madison Avenue, New York, NY 10029, USA.
  • Department of Medicine, Columbia University, New York, NY 10032, USA.

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • The Chan Zuckerberg Initiative
  • National Institute on Aging
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • Thompson Foundation
  • Henry and Marilyn Taub Foundation

Zitieren

APA

Haage, V., Tuddenham, J. F., Comandante-Lou, N., Bautista, A. R., Monzel, A. S., Garcia, F. G., Chiu, R., Fujita, M., Bhattarai, P., White, C. C., Patel, R., Buonfiglioli, A., Idiarte, J., Herman, M., Rinderspacher, A., Mela, A., Zhao, W., Argenziano, M. G., Furnari, J. L., …, & De Jager, P. L. (2026). Topoisomerase I inhibition yields a CD74high/MHChigh human microglial subtype with enhanced Aβ uptake. Cell Reports, 45(10), 118031. https://doi.org/10.1016/j.celrep.2026.118031

Vancouver

Haage V, Tuddenham JF, Comandante-Lou N, Bautista AR, Monzel AS, Garcia FG, et al. Topoisomerase I inhibition yields a CD74high/MHChigh human microglial subtype with enhanced Aβ uptake. Cell Reports. 2026;45(10):118031. doi:10.1016/j.celrep.2026.118031

BibTeX
@article{Haage2026,
  author = {Haage, Verena and Tuddenham, John F and Comandante-Lou, Natacha and Bautista, Alex R and Monzel, Anna S and Garcia, Frankie G and Chiu, Rebecca and Fujita, Masashi and Bhattarai, Prabesh and White, Charles C and Patel, Ronak and Buonfiglioli, Alice and Idiarte, Juan and Herman, Mathieu and Rinderspacher, Alison and Mela, Angeliki and Zhao, Wenting and Argenziano, Michael G and Furnari, Julia L and Banu, Matei A and Landry, Donald W and Bruce, Jeffrey N and Canoll, Peter and Zhang, Ya and Nuriel, Tal and Sproul, Andrew A and de Witte, Lotje D and Sims, Peter A and Menon, Vilas and Kizil, Caghan and Picard, Martin and De Jager, Philip L},
  title = {Topoisomerase I inhibition yields a CD74high/MHChigh human microglial subtype with enhanced Aβ uptake},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {10},
  pages = {118031},
  doi = {10.1016/j.celrep.2026.118031}
}
Kostenlos starten →